Boston Partners

SEC CIK: 0001386060
Latest filing: Aug 4, 2026

SEC filings (opens in a new tab)

ELV holding history

Elevance Health, Inc. in every 13F filed by Boston Partners, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ELV overview All 13F holders of ELV Full Q2 2026 holdings

Shares (Q2 2026): 137,407
Value: $53.2M
% of portfolio: <0.1%
Quarters held: 22; Since Q1 2021

Holdings of ELV by Boston Partners, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	137,407	$53.2M	<0.1%	−4,648−3.3%	Reduced	Holders
Q1 2026	142,055	$41.6M	<0.1%	−5,754−3.9%	Reduced	Holders
Q4 2025	147,809	$51.9M	0.1%	−7,473−4.8%	Reduced	Holders
Q3 2025	155,282	$50.3M	0.1%	−799,345−83.7%	Reduced	Holders
Q2 2025	954,627	$367.0M	0.4%	+97,890+11.4%	Added	Holders
Q1 2025	856,737	$372.0M	0.4%	+605,689+241.3%	Added	Holders
Q4 2024	251,048	$92.6M	0.1%	−135,383−35.0%	Reduced	Holders
Q3 2024	386,431	$200.7M	0.2%	−1,271−0.3%	Reduced	Holders
Q2 2024	387,702	$210.1M	0.3%	−2,262−0.6%	Reduced	Holders
Q1 2024	389,964	$202.3M	0.2%	−46,233−10.6%	Reduced	Holders
Q4 2023	436,197	$205.7M	0.3%	−65,885−13.1%	Reduced	Holders
Q3 2023	502,082	$218.6M	0.3%	+25,301+5.3%	Added	Holders
Q2 2023	476,781	$211.9M	0.3%	−3,875−0.8%	Reduced	Holders
Q1 2023	480,656	$221.0M	0.3%	−112,836−19.0%	Reduced	Holders
Q4 2022	593,492	$304.4M	0.4%	−16,246−2.7%	Reduced	Holders
Q3 2022	609,738	$277.1M	0.4%	−24,997−3.9%	Reduced	Holders
Q2 2022	634,735	$306.3M	0.4%	+2,508+0.4%	Added	Holders
Q1 2022	632,227	$310.6M	0.4%	+4,699+0.7%	Added	Holders
Q4 2021	627,528	$290.8M	0.4%	−20,463−3.2%	Reduced	Holders
Q3 2021	647,991	$241.6M	0.3%	−1,451,782−69.1%	Reduced	Holders
Q2 2021	2,099,773	$801.8M	1.0%	+3900.0%	Added	Holders
Q1 2021	2,099,383	$754.1M	1.0%	–	–	Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.